Five-target drug beats GLP-1/GIP therapy in obese diabetic mice
A targeted GLP-1–GIP–lanifibranor conjugate delivered broad metabolic benefits in obese mice, pointing to a potential new generation of multi-pathway therapies…
A targeted GLP-1–GIP–lanifibranor conjugate delivered broad metabolic benefits in obese mice, pointing to a potential new generation of multi-pathway therapies…
A multicondition polygenic risk report validated in U.S. health systems could help clinicians spot inherited cardiovascular risk earlier, refine prevention…
A new benchmark shows that passing medical exams is not enough; clinical AI agents must gather information, handle uncertainty, use…
A simple tool, developed by researchers at Queen Mary University of London and the Berlin Institute of Health at Charité,…
An intestinal pathogen reshapes the gut environment to fuel its own colonization and cause diseases, a multi-institutional team including researchers…
Symptoms such as fatigue, loss of appetite, altered sleep, and social withdrawal are often treated as inconvenient side effects of…
Targeting only a small group of well-connected individuals with smoking reduction interventions produces the largest reductions in smoking, researchers report.…
A new study reveals that ingestions of water beads by young children have surged in recent years. Researchers at the…
Immunotherapy has become a standard of care in treating high-risk, early-stage breast cancers, yet it has had limited success in…
A new randomized clinical trial provides some of the clearest evidence to date that what we eat can meaningfully reshape…